iShares Biotechnology ETF Stock Forecast, Price & News

-0.16 (-0.09 %)
(As of 09/22/2021 04:02 PM ET)
Today's Range
50-Day Range
52-Week Range
Volume94,985 shs
Average Volume3.16 million shs
Market Capitalization$11.16 billion
P/E RatioN/A
Dividend Yield0.17%
30 days | 90 days | 365 days | Advanced Chart
Receive IBB News and Ratings via Email

Sign-up to receive the latest news and ratings for iShares Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer iShares
Fund NameiShares Biotechnology ETF
Tax ClassificationRegulated Investment Company
Inception Date2/5/2001
Fund ManagerDiane Hsiung, Jennifer Hsui, Greg Savage, Alan Mason

Fund Focus

Asset ClassEquity
BenchmarkICE Biotechnology Index
FocusHealth Care
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$11.16 billion
Average Daily Volume$2.03 million

ETF Expenses

Management Fee0.45%
Other Expenses0.00%
Total Expenses0.45%
Fee Waiver0.00%
Net Expenses0.45%

Administrator, Advisor and Custodian

AdministratorState Street Bank and Trust Company
AdvisorBlackRock Fund Advisors
CustodianState Street Bank and Trust Company
DistributorBlackRock Investments, LLC
Transfer AgentState Street Bank and Trust Company
Lead Market Maker

Geographic Exposure of IBB

Currency Exposure of IBB

Sector Exposure of IBB

Industry Exposure of IBB

speech bubbles
speech bubbles

iShares Biotechnology ETF (NYSEARCA:IBB) Frequently Asked Questions

What stocks does MarketBeat like better than iShares Biotechnology ETF?

Wall Street analysts have given iShares Biotechnology ETF a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but iShares Biotechnology ETF wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Is iShares Biotechnology ETF a good dividend stock?

iShares Biotechnology ETF pays an annual dividend of $0.28 per share and currently has a dividend yield of 0.17%.
View iShares Biotechnology ETF's dividend history.

What other stocks do shareholders of iShares Biotechnology ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other iShares Biotechnology ETF investors own include NVIDIA (NVDA), The Walt Disney (DIS), Intel (INTC), AbbVie (ABBV), Alibaba Group (BABA), Pfizer (PFE), PayPal (PYPL), salesforce.com (CRM), Merck & Co., Inc. (MRK) and Micron Technology (MU).

What is iShares Biotechnology ETF's stock symbol?

iShares Biotechnology ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "IBB."

How do I buy shares of iShares Biotechnology ETF?

Shares of IBB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is iShares Biotechnology ETF's stock price today?

One share of IBB stock can currently be purchased for approximately $171.40.

How much money does iShares Biotechnology ETF make?

iShares Biotechnology ETF has a market capitalization of $11.16 billion.

This page was last updated on 9/22/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.